Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

1,056 total articles

Buy Microsoft on Weakness: A Tactical Long with Defined Risk

Buy Microsoft on Weakness: A Tactical Long with Defined Risk

Microsoft's stock has sold off sharply into technical and sentiment support. Fundamentals remain intact: $2.95T market cap, 30% ROE, $77B of free cash flow and a modest debt load. With RSI near 32 and short-interest moderate, this is a tactical long for patient traders who want defined risk and a clear thesis for recovery over the next 45 trading d…

LegalZoom: Subscription Momentum and Cash Flow Make a Compelling Long

LegalZoom: Subscription Momentum and Cash Flow Make a Compelling Long

LegalZoom (LZ) has been punished with AI angst and recent share weakness, but the underlying business is producing durable subscription revenue, strong free cash flow ($155.8M) and carries virtually no debt. With a market cap near $1.19B and an attractive FCF yield, the risk/reward looks favorable for a long position targeting a reversion toward hi…

CarGurus: Buy the Dip as AI Products and Dealer Adoption Drive a Re-Rate

CarGurus: Buy the Dip as AI Products and Dealer Adoption Drive a Re-Rate

CarGurus (CARG) is a $2.9B online automotive marketplace that combines a high-return core marketplace with a growing digital wholesale business and new AI-driven products. At roughly $29.25 today, the stock offers a clear asymmetric trade: reasonable valuation (P/E ~19.8; EV/EBITDA ~10.4), strong free cash flow ($272M last period), and meaningful u…

Meta’s Data Moat Is Getting Harder to Penetrate — Time to Lean Long

Meta’s Data Moat Is Getting Harder to Penetrate — Time to Lean Long

Meta is investing aggressively in infrastructure and data-quality guardrails that make its advertising and AI personalization increasingly defensible. With a market cap around $1.66T, healthy free cash flow and improving AI partnerships, the risk/reward favors a long position over the next 180 trading days, provided you respect valuation and set a …

American Tower: Early Signs of a Turnaround - Tactical Long Idea

American Tower: Early Signs of a Turnaround - Tactical Long Idea

American Tower looks poised to re-rate as its CoreSite data center business captures AI-driven colocation demand and the stock shows improving technicals. The company offers a 3.6% yield and FCF of roughly $3.7B, supporting a tactical long trade sized for a long-term (180 trading days) horizon. Entry $185.025, stop $170.00, target $215.00.

ARQT: Growth Matures but ZORYVE Compounding Still Intact

ARQT: Growth Matures but ZORYVE Compounding Still Intact

Arcutis has doubled in a year on accelerating ZORYVE sales and encouraging guidance. Revenue upside is in the numbers — 2026 net product sales guidance of $455-470M implies rapid compounding, but valuation (EV/sales ~11x) already prices a lot of the story. This trade targets further multiple expansion into secular adoption while protecting capital …

Why Amazon's Math Doesn't Work: A Short Trade Plan

Why Amazon's Math Doesn't Work: A Short Trade Plan

Amazon (AMZN) looks great in headlines: top of the Fortune 500 and AWS still dominant. But under the hood the stock is priced for near-perfection, free cash flow recently turned negative, and technical momentum is failing. This actionable short trade targets a retreat toward the $170 area over the next 45 trading days with a $220 stop.

Corcept Therapeutics: Short-Term Shock, Long-Term Optionality—Buy the Dip for Relacorilant's Oncology Upside

Corcept Therapeutics: Short-Term Shock, Long-Term Optionality—Buy the Dip for Relacorilant's Oncology Upside

Corcept (CORT) plunged after a 12/31/2025 FDA Complete Response Letter for relacorilant tied to hypercortisolism. That sell-off priced in a lot of regulatory and litigation downside; meanwhile relacorilant's oncology potential, especially in platinum-resistant ovarian cancer, remains underappreciated. This trade idea lays out a tactical long with c…

TPL: Momentum in the Dirt - A Defined-Risk Long on Texas Pacific Land

TPL: Momentum in the Dirt - A Defined-Risk Long on Texas Pacific Land

Texas Pacific Land (TPL) is trading with clear momentum after an energy-led rally. The business earns recurring royalties, land-use fees and growing water services revenue in the Permian Basin. Valuation is rich, but a short-term momentum trade with strict risk controls is attractive: entry $487.00, stop $435.00, target $600.00 over a mid-term (45 …

Blue Owl: Dividend Cut Priced In — A Tactical Long with Defined Risk

Blue Owl: Dividend Cut Priced In — A Tactical Long with Defined Risk

Blue Owl (OWL) has been hammered by redemptions, lawsuits and distribution uncertainty. The stock trades near its 52-week low with RSI around 30, heavy short interest and an attractive headline yield. We think the worst of headline-driven selling is largely priced in and propose a defined-risk long targeting a recovery to the mid-teens over a 180-t…